BKV Corporation (NYSE:BKV - Free Report) - KeyCorp decreased their Q1 2025 EPS estimates for shares of BKV in a research note issued to investors on Sunday, April 20th. KeyCorp analyst T. Rezvan now forecasts that the company will earn $0.15 per share for the quarter, down from their previous estimate of $0.25. KeyCorp has a "Overweight" rating and a $25.00 price objective on the stock. The consensus estimate for BKV's current full-year earnings is ($1.82) per share. KeyCorp also issued estimates for BKV's Q2 2025 earnings at $0.15 EPS, Q4 2025 earnings at $0.28 EPS and Q4 2026 earnings at $0.46 EPS.
BKV (NYSE:BKV - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.10) by $0.11. The company had revenue of $119.78 million during the quarter, compared to analyst estimates of $183.77 million.
BKV has been the subject of several other reports. Truist Financial decreased their target price on shares of BKV from $31.00 to $30.00 and set a "buy" rating for the company in a research report on Monday, March 17th. Barclays decreased their target price on shares of BKV from $30.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday. Eight research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, BKV has a consensus rating of "Buy" and a consensus price target of $27.75.
Read Our Latest Analysis on BKV
BKV Stock Performance
BKV stock traded up $0.03 during trading hours on Tuesday, hitting $18.38. The company's stock had a trading volume of 241,593 shares, compared to its average volume of 472,555. BKV has a 12 month low of $15.00 and a 12 month high of $26.78. The stock has a 50 day moving average price of $19.43 and a two-hundred day moving average price of $21.12.
Institutional Trading of BKV
A number of institutional investors and hedge funds have recently added to or reduced their stakes in BKV. Driehaus Capital Management LLC bought a new stake in BKV in the fourth quarter valued at about $9,553,000. Geode Capital Management LLC bought a new stake in BKV in the fourth quarter valued at about $7,728,000. Bank of New York Mellon Corp bought a new stake in BKV in the fourth quarter valued at about $695,000. Corebridge Financial Inc. bought a new stake in BKV in the fourth quarter valued at about $170,000. Finally, SG Americas Securities LLC bought a new stake in BKV in the fourth quarter valued at about $157,000.
Insider Buying and Selling
In other news, CFO David Tameron sold 5,000 shares of the business's stock in a transaction dated Thursday, April 3rd. The shares were sold at an average price of $20.03, for a total transaction of $100,150.00. Following the transaction, the chief financial officer now owns 47,779 shares in the company, valued at approximately $957,013.37. The trade was a 9.47 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Ethan Ngo sold 21,667 shares of the business's stock in a transaction dated Thursday, April 3rd. The stock was sold at an average price of $20.09, for a total transaction of $435,290.03. Following the transaction, the insider now owns 286,008 shares in the company, valued at approximately $5,745,900.72. The trade was a 7.04 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 41,667 shares of company stock valued at $851,490.
About BKV
(
Get Free Report)
BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.
See Also

Before you consider BKV, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.
While BKV currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.